0.15 USD
↘ 0.02 (12.20%)AT CLOSE (11:59 AM EDT)
Virax Biolabs Group Limited Ordinary Shares
VRAXNASDAQ • USD
0.15
↘ 0.00 (2.49%)
POST MARKET (AS OF 05:03 PM EDT)
Post Market
AS OF 05:03 PM EDT
0.15
↘ 0.00 (2.49%)
Market: OPEN
Open?$0.16
High?$0.16
Low?$0.15
Prev. Close?$0.17
Volume?1.3M
Avg. Volume?N/A
VWAP?$0.16
Bid / Ask
Bid?$0.15 × 400
Ask?$0.16 × 1.6K
Spread?$0.01
Midpoint?$0.15
Valuation & Ratios
Market Cap?1.3M
Shares Out?4.3M
Float?5.5M
Float %?73.5%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.